Stock Code: BMY
Company Details:
Bristol-Myers Squibb Overview
Bristol-Myers Squibb (BMS) is a global biopharmaceutical company that is involved in discovering, developing, manufacturing, marketing, and distributing a wide range of products aimed at treating various diseases. Its therapeutic focus spans several areas including oncology, immunology, cardiovascular diseases, hematology, fibrotic diseases, and neuroscience.
BMS\'s Therapeutic Portfolio
BMS\'s portfolio includes several high-profile medications for different health conditions. For instance, Eliquis is prescribed to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation and to treat deep vein thrombosis and pulmonary embolism. The company also offers Opdivo, an immunotherapy used in the treatment of various cancers, such as lung, melanoma, and bladder cancer.
Other Key Products
In addition to cancer treatments, BMS provides drugs like Orencia, used for rheumatoid arthritis and psoriatic arthritis, and Sprycel, for treating chronic myeloid leukemia. Other notable products include Yervoy for melanoma, Reblozyl for anemia, and Zeposia for multiple sclerosis.
Company History and Global Presence
With a rich history dating back to its founding in 1887, the company, which was originally known as Bristol-Myers, is headquartered in Princeton, New Jersey. It serves a global market, distributing its products to wholesalers, hospitals, pharmacies, and government entities, among other stakeholders.
Bristol-Myers Squibb Company
Route 206 & Province Line Road
Princeton, NJ 08543
United States
609 252 4621
https://www.bms.com
Sector:
Healthcare
Industry: Drug Manufacturers - General
Full Time Employees:
34,100